Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial

Overview of attention for article published in Lancet Infectious Diseases, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs: 1 blog

twitter: 25 X users

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 25 X posts from 25 X users, with an upper bound of 136,945 followers.

RT @GMalavige: Importance of #dengue human challenge studies to answer key questions in dengue. Despite individuals having neutralising Ab…

Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial https://t.co/hMYRHZEk2d

RT @GMalavige: Importance of #dengue human challenge studies to answer key questions in dengue. Despite individuals having neutralising Ab…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 21 additional X posts.